Dow Inc posted Q1 2025 EPS of €0.02, reversing a consensus loss forecast, alongside revenue of €9.08 billion exceeding targets. Profitability recovery in a major chemical entity suggests stabilizing demand conditions within the industrial materials sector. Surpassing estimates enhances Dow Inc's liquidity position, potentially supporting capital allocation strategies amid volatile commodity cycles.
2 articles
Dow Inc reported Q1 2025 earnings with an EPS of €0.02, beating consensus estimates of -€0.01. Revenue reached €9.08 billion, surpassing expectations of €8.92 billion.
Xylem reported record adjusted EPS of $1.46 for Q2, raising full-year guidance driven by robust demand in data centers and industrial markets. Its backlog grew to $5.3 billion, supported by strategic
ChemBrief